Bladder cancer and urine bacteria study
Part of Cancer, Infections, Kidney & urinary clinical trials.
This study looks at bacteria in urine and the bladder to understand if they play a role in causing bladder cancer. Researchers will compare samples from men with bladder cancer and healthy controls.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man over 18 years old.
- You have been diagnosed with bladder cancer using imaging (ultrasound or CT scan) or urine tests.
- Your bladder cancer was confirmed by a biopsy or during a diagnostic procedure (cystoscopy).
- You have not had radiation therapy to your bladder or nearby organs.
- You have not received BCG immunotherapy or chemotherapy directly into your bladder.
- You have not had chemotherapy before surgery for this cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares the bacteria in urine of men with bladder cancer to those with other urinary issues and healthy men. For bladder cancer patients, it looks at differences before a planned surgery to remove the bladder.
This study looks at the bacteria in your gut and bladder to understand how they may relate to bladder cancer. It is for men who are having their first tumor removal for suspected bladder cancer, and helps researchers learn if the microbiome plays a role.
This study looks at the bacteria in your body (microbiome) to see if they can help predict how your bladder cancer will progress. It aims to find patterns that might guide better treatment decisions.
This study looks at how the bladder reacts to a standard treatment called BCG, which is given after surgery for early-stage bladder cancer. By checking the tissue and urine before treatment, the study aims to understand if the bladder is ready for BCG therapy, which could help improve outcomes.
This study tests a urine test that may help find bladder cancer early without needing invasive procedures. It is for people with high-grade or high-risk non-muscle-invasive bladder cancer who are receiving or have received BCG treatment.
This study follows people with urothelial cancer and certain rare genital (genitourinary) cancers over time to learn how these diseases progress. It may help researchers understand patterns of symptoms and outcomes, even if it is not a drug trial.
Hear when a new Microbiota in Patients With Urinary Bladder Carcinoma in Urine and Cancer Tissues trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.